Natco Pharma Outperforms Sector Amid Broader Market Decline and Year-to-Date Challenges

Natco Pharma has shown significant activity today, with the stock rising by 5.23% as of June 30, 2025. This performance has allowed Natco to outperform its sector by 4.1%. Over the past two days, the stock has experienced consecutive gains, accumulating a total return of 6.23%. During today's trading, Natco Pharma reached an intraday high of Rs 927, marking a 4.89% increase.
In terms of moving averages, Natco Pharma's stock is currently above its 5-day, 20-day, 50-day, and 100-day moving averages, although it remains below the 200-day moving average.

In the broader market context, the Sensex opened flat but subsequently fell by 405.93 points, closing at 83,621.40, reflecting a decline of 0.52%. Despite this, the Sensex is still close to its 52-week high and is trading above its 50-day moving average, which is positioned above the 200-day moving average.

While Natco Pharma's recent performance has been strong, it is important to note that its year-to-date performance remains down by 32.84%, contrasting with the Sensex's gain of 7.02% during the same period.